This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.81% per year. These returns cover a period from January 1, 1988 through September 1, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
UnitedHealth Group, Inc. is the largest health care services company in the world, serving over 50 million individuals in the United States as of 2019 and over 5 million internationally. The company provides a wide range of health care products and services, such as health maintenance organizations (HMOs), point of service plans (POS), preferred provider organizations (PPOs), and managed fee-for-service programs. UnitedHealth has the largest and most diverse membership base within the managed-care organization market, which gives it significant competitive advantages. It also has built its prescription drug business through OptumRx division, with the acquisition of Catamaran in 2015.
Molina Healthcare (MOH) Tops Q1 Earnings, Updates '18 View
by Zacks Equity Research
Bottom-line growth plus lower expenses as well as medical care cost drive Molina Healthcare's (MOH) first-quarter results.
Universal Health (UHS) Q1 Earnings & Revenues Lag Estimates
by Zacks Equity Research
Universal Health (UHS) posts a solid Q1 driven by higher revenues.
Anthem (ANTM) Beats on Q1 Earnings, Raises '18 Guidance
by Zacks Equity Research
Strong performance across segments supports Anthem's (ANTM) first-quarter results.
Centene (CNC) Q1 Earnings & Revenues Top, '18 View Lowered
by Zacks Equity Research
Centene (CNC) delivers strong first-quarter results on the back of significant membership growth.
Top Stock Reports for UnitedHealth, Netflix & Caterpillar
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including UnitedHealth (UNH), Netflix (NFLX) and Caterpillar (CAT).
UnitedHealth (UNH) Q1 Earnings & Revenues Top, View Lifted
by Zacks Equity Research
UnitedHealth (UNH) Q1 earnings reflect double-digit growth across each business line.
New Construction Data, Q1 Earnings In Focus
by Zacks Equity Research
New Construction Data, Q1 Earnings In Focus
Tax Day Not So Taxing (for Corporations, Housing)
by Mark Vickery
Strength in Q1 earnings season, at least in these early stages, has helped bolster market indexes. This continues ahead of Tuesday's market open.
UnitedHealth (UNH) Q1 Earnings Beat on Higher Revenues
by Zacks Equity Research
UnitedHealth (UNH) Q1 earnings reflects increase in revenues offset higher expenses driving margin expansion.
UnitedHealth (UNH) Q1 Earnings to Gain From Optum Revenues
by Zacks Equity Research
UnitedHealth (UNH) Q1 earnings should see an upside from higher revenues in its health services segment named Optum.
Top Research Reports for ExxonMobil, AT&T & Barclays
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including ExxonMobil (XOM), AT&T (T) and Barclays (BCS).
Will UnitedHealth (UNH) Q1 Earnings Buoy on Revenue Growth?
by Zacks Equity Research
UnitedHealth's (UNH) Q1 earnings should see an upside from revenue growth at both its segments - Optum and UnitedHealthcare.
Medicare Rate Up More than Expected, Health Insurers to Gain
by Zacks Equity Research
Increase in Medicare Advantage reimburse rates bodes well for health insurers.
Top Research Reports for Facebook, UnitedHealth & Pfizer
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including Facebook (FB), UnitedHealth (UNH) and Pfizer (PFE).
Top Research Reports for UnitedHealth, Morgan Stanley & Anheuser-Busch
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including UnitedHealth (UNH), Morgan Stanley (MS) and Anheuser-Busch (BUD).
Cigna on Raters' Radar After Express Scripts Bid, Stock Down
by Zacks Equity Research
Cigna (CI) gets rating downgrade on a number of concerns related to the Express Scripts deal.
Buy These 3 Stocks as Healthcare Continues to Shift Gears
by Zacks Equity Research
Mergers and acquisition in the healthcare industry should aid long term-growth for companies.
5 Reasons Why Anthem (ANTM) is a Lucrative Investment Option
by Zacks Equity Research
Anthem (ANTM) appears an impressive investment option on the back of rising membership, favorable investment income as well as solid financial health.
Universal Health (UHS) Q4 Earnings, Revenues Beat Estimates
by Zacks Equity Research
Solid segmental performance drives Universal Health's (UHS) fourth-quarter results.
Community Health's (CYH) Q4 Loss Narrower Than Expected
by Zacks Equity Research
Lower admission hurts Community Health's (CYH) fourth-quarter results.
Teladoc (TDOC) Q4 Loss Wider Than Expected, Revenues Beat
by Zacks Equity Research
Teladoc (TDOC) earnings were aided by membership growth and increased visits.
Envision Healthcare (EVHC) Q4 Earnings Beat, Revenues Rise
by Zacks Equity Research
Envision Healthcare (EVHC) earnings benefited from higher revenues partly offset by an increase in expenses.
LifePoint Health (LPNT) Q4 Earnings Miss on Lower Revenues
by Zacks Equity Research
LifePoint Health (LPNT) fails to beat the earnings and revenue estimates in the fourth quarter. Equivalent admissions decline 3% year over year.
Select Medical (SEM) Q4 Earnings Top Estimates, Keeps View
by Zacks Equity Research
Solid segmental performances aid Select Medical's (SEM) Q4 earnings.
Anthem Buys America's 1st Choice, Expands in Medicare Market
by Zacks Equity Research
Anthem's (ANTM) acquisition of America's 1st Choice falls in line with its strategy to expand in the Medicare Advantage market.